Aberrant promoter hypermethylation in biliary tract carcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 13, Issue 4, 2006, Pages 296-305

  Kohya, Naohiko ^a   Koga, Yasuo ^a   Kitajima, Yoshihiko ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Bile duct carcinoma; Gallbladder carcinoma; Promoter methylation

Indexed keywords

APC PROTEIN; CADHERIN; CARCINOEMBRYONIC ANTIGEN; DEATH ASSOCIATED PROTEIN KINASE; PROTEIN MLH1; PROTEIN P14; PROTEIN P15; PROTEIN P16INK4A; PROTEIN P57; PROTEIN P73; PROTEIN TYROSINE PHOSPHATASE SHP 1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; SUPPRESSOR OF CYTOKINE SIGNALING 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR RUNX3; UVOMORULIN;

BILE DUCT CARCINOMA; CANCER SURVIVAL; EPIGENETICS; GENE REPRESSION; GENE SILENCING; HUMAN; METHYLATION; MOLECULAR DYNAMICS; POLYMERASE CHAIN REACTION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BILE DUCT NEOPLASMS; BILIARY TRACT NEOPLASMS; CELL CYCLE; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DISEASE PROGRESSION; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; EPIGENESIS, GENETIC; GALLBLADDER NEOPLASMS; GENE SILENCING; HUMANS; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 33746327153     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-005-1058-0     Document Type: Review

References (83)

1. DE Henson J Albores-Saavedra D Corle 1992 Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates Cancer 70 1498-501 1516001 1:STN:280:By2A1cnktFc%3D 10.1002/ 1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C
2. DE Henson J Albores-Saavedra D Corle 1992 Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates Cancer 70 1493-7 1516000 1:STN:280:By2A1cnktFY%3D 10.1002/ 1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U
3. PC de Groen GJ Gores NF LaRusso LL Gunderson DM Nagorney 1999 Biliary tract cancers N Engl J Med 341 1368-78 10536130 1:STN:280:DyaK1MvltV2itQ%3D%3D 10.1056/NEJM199910283411807
4. T Patel 2002 Worldwide trends in mortality from biliary tract malignancies BMC Cancer 2 1011991810 10.1186/1471-2407-2-10
5. A Tavani E Negri C La Vecchia 1996 Biliary tract tumors Ann Ist Super Sanita 32 615-9 9382430 1:STN:280:ByiH3c7nsFc%3D
6. Y Nimura 2002 Extended surgery in bilio-pancreatic cancer: The Japanese experience Semin Oncol 29 6 Suppl 20 17-22 12577229
7. K Hanada M Itoh K Fujii A Tsuchida H Ooishi G Kajiyama 1996 K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct Cancer 77 452-8 8630951 1:CAS:528:DyaK28Xht12jsL4%3D 10.1002/ (SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M
8. T Itoi H Watanabe Y Ajioka Y Oohashi K Takel K Nishikura 1996 APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis Pathol Int 46 333-40 8809879 1:CAS:528:DyaK28XltVajtb4%3D
9. M Imai T Hoshi K Ogawa 1994 K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis Cancer 73 2727-33 8194013 1:CAS:528:DyaK2MXisVyqsA%3D%3D 10.1002/ 1097-0142(19940601)73:11<2727::AID-CNCR2820731113>3.0.CO;2-#
10. E Sasatomi O Tokunaga K Miyazaki 2000 Precancerous conditions of gallbladder carcinoma: Overview of histopathologic characteristics and molecular genetic findings J Hepatobiliary Pancreat Surg 7 556-67 11180887 1:STN:280:DC%2BD3M3gtFeksw%3D%3D 10.1007/s005340070004
11. T Ajiki H Onoyama M Yamamoto K Asaka T Fujimori S Maeda 1996 p53 Protein expression and prognosis in gallbladder carcinoma and premalignant lesions Hepatogastroenterology 43 521-6 8799388 1:STN:280:BymA1M3mtVQ%3D
12. S Yoshida T Todoroki Y Ichikawa S Hanai H Suzuki M Hori 1995 Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers Cancer Res 55 2756-60 7796400 1:CAS:528:DyaK2MXmsFyksrk%3D
13. II Wistuba J Albores-Saavedra 1999 Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma J Hepatobiliary Pancreat Surg 6 237-44 10526058 1:STN:280:DyaK1Mvlsleiuw%3D%3D 10.1007/s005340050113
14. DE Hansel A Rahman M Hidalgo PJ Thuluvath KD Lillemoe R Shulick 2003 Identification of novel cellular targets in biliary tract cancers using global gene expression technology Am J Pathol 163 217-29 12819026 1:CAS:528:DC%2BD3sXmtVWrtb0%3D
15. SU Kass D Pruss AP Wolffe 1997 How does DNA methylation repress transcription? Trends Genet 13 444-9 9385841 1:CAS:528:DyaK2sXnsValsbw%3D 10.1016/S0168-9525(97)01268-7
16. A Razin H Cedar 1991 DNA methylation and gene expression Microbiol Rev 55 451-8 1943996 1:CAS:528:DyaK3MXmsV2js7g%3D
17. PA Jones PW Laird 1999 Cancer epigenetics comes of age Nat Genet 21 163-7 9988266 1:CAS:528:DyaK1MXpsVClug%3D%3D 10.1038/5947
18. M Esteller PG Corn SB Baylin JG Herman 2001 A gene hypermethylation profile of human cancer Cancer Res 15 61 3225-9
19. SG Kim AO Chan TT Wu JP Issa SR Hamilton A Rashid 2003 Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas Gastroenterology 124 1300-10 12730870 10.1016/ S0016-5085(03)00278-6
20. S Lee WH Kim HY Jung MH Yang Kang GH. Aberrant 2002 CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma Am J Pathol 161 1015-22 12213730 1:CAS:528:DC%2BD38XnsFOis74%3D
21. N Wong L Li K Tsang PB Lai KF To PJ Johnson 2002 Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma J Hepatol 37 633-9 12399230 1:CAS:528:DC%2BD38XotVKktLw%3D 10.1016/ S0168-8278(02)00269-6
22. A Tannapfel F Sommerer M Benicke L Weinans A Katalinic F Geissler et al 2002 Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma J Pathol 197 624-31 12210082 1:CAS:528:DC%2BD38Xntleku78%3D 10.1002/path.1139
23. A Tannapfel M Benicke A Katalinic D Uhlmann F Kockerling J Hauss et al 2002 Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver Gut 47 721-7 10.1136/ gut.47.5.721
24. K Caca J Feisthammel K Klee A Tannapfel H Witzigmann C Wittekind et al 2002 Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines Int J Cancer 97 481-8 11802210 1:CAS:528:DC%2BD38XkvFegtA%3D%3D 10.1002/ ijc.1639
25. MG House II Wistuba P Argani M Guo RD Schulick RH Hruban et al 2003 Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer Ann Surg Oncol 10 882-9 14527906 10.1245/ ASO.2003.02.014
26. JR Melki PC Vincent RD Brown SJ Clark 2000 Hypermethylation of E-cadherin in leukemia Blood 95 3208-13 10807790 1:CAS:528:DC%2BD3cXjt1Cjs78%3D
27. JL Ku KA Yoon IJ Kim WH Kim JY Jang KS Suh et al. 2002 Establishment and characterisation of six human biliary tract cancer cell lines Br J Cancer 87 187-93 12107841 1:CAS:528:DC%2BD38XltFeksL8%3D 10.1038/ sj.bjc.6600440
28. M Mori K Miyazaki K Kitahara S Mukai K Motoyama G Edakuni 2000 Relationship between prognosis of galblader carcinoma patients and the expression of E-cadherin/alpha-catenin Jpn J Gastroenterol Surg 33 584-9
29. N Kohya Y Kitajima W Jiao K Miyazaki 2003 Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression Int J Cancer 104 44-53 12532418 1:CAS:528:DC%2BD3sXhtlCgurc%3D 10.1002/ijc.10920
30. Y Koga Y Kitajima A Miyoshi K Sato K Kitahara H Soejima et al 2005 Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers Ann Surg Oncol 12 354-63 15915369 10.1245/ASO.2005.07.020
31. T Tozawa G Tamura T Honda S Nawata W Kimura N Makino et al 2004 Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients Cancer Sci 95 736-40 15471559 1:CAS:528:DC%2BD2cXpvFOgurc%3D 10.1111/j.1349-7006.2004.tb03254.x
32. T Takahashi N Shivapurkar E Riquelme H Shigematsu J Reddy M Suzuki et al 2004 Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis Clin Cancer Res 10 18 Pt 1 6126-33 15447999 1:CAS:528:DC%2BD2cXnvVOjs78%3D 10.1158/1078-0432.CCR-04-0579
33. T Nobori K Miura DJ Wu A Lois K Takabayashi DA Carson 1994 Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature 21 368 753-6 10.1038/368753a0
34. A Kamb NA Gruis J Weaver-Feldhaus Q Liu K Harshman SV Tavtigian et al 1994 A cell cycle regulator potentially involved in genesis of many tumor types Science 264 436-40 8153634 1:CAS:528:DyaK2cXktVKhtb0%3D
35. A Okamoto DJ Demetrick EA Spillare K Hagiwara SP Hussain WP Bennett 1994 Mutations and altered expression of p16INK4 in human cancer Proc Natl Acad Sci U S A 91 11045-9 1:CAS:528:DyaK2MXitV2rsbw%3D
36. A Merlo JG Herman L Mao DJ Lee E Gabrielson PC Burger et al1995 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 686-92 7585152 1:CAS:528:DyaK2MXms1Kgtr4%3D 10.1038/nm0795-686
37. M Gonzalez-Zulueta CM Bender AS Yang T Nguyen RW Beart JM Van Tornout et al 1995 Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing Cancer Res 55 4531-5 7553622 1:CAS:528:DyaK2MXoslWmsrY%3D
38. A Canero GJ Hannon 1998 The INK4 family of CDK inhibitors Curr Top Microbiol Immunol 227 43-55
39. DE Quelle F Zindy RA Ashmun CJ Sherr 1995 Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 993-1000 8521522 1:CAS:528:DyaK2MXhtVSnu7fM 10.1016/0092-8674(95)90214-7
40. S Stone P Jiang P Dayananth SV Tavtigian H Katcher D Parry et al1995 Complex structure and regulation of the P16 (MTS1) locus Cancer Res 15 55 2988-94 55
41. M Serrano GJ Hannon D Beach 1993 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 704-7 8259215 1:CAS:528:DyaK2cXhsFOgu7Y%3D 10.1038/366704a0 704-7
42. RA Weinberg 1995 The retinoblastoma protein and cell cycle control Cell 81 323-30 7736585 1:CAS:528:DyaK2MXlsFSrs7k%3D 10.1016/ 0092-8674(95)90385-2
43. S Yoshida T Todoroki Y Ichikawa S Hanai H Suzuki M Hori et al 1995 Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers Cancer Res 55 2756-60 7796400 1:CAS:528:DyaK2MXmsFyksrk%3D
44. Y Imai N Tsurutani H Oda Y Nakatsuru T Inoue T Ishikawa 1997 p16INK4 gene mutations are relatively frequent in ampullary carcinomas Jpn J Cancer Res 88 941-6 9414654 1:CAS:528:DyaK2sXnt1Cqurg%3D
45. II Wistuba K Sugio J Hung Y Kishimoto AK Virmani I Roa et al 1995 Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile Cancer Res 55 2511-15 7780959 1:CAS:528:DyaK2MXmtlWrsLY%3D
46. E Hidaka A Yanagisawa Y Sakai M Seki T Kitagawa T Setoguchi et al 1999 Losses of heterozygosity on chromosomes 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis J Cancer Res Clin Oncol 125 439-43 10480335 1:CAS:528:DyaK1MXlsF2nsLk%3D 10.1007/s004320050300
47. SA Ahrendt CF Eisenberger L Yip A Rashid JT Chow HA Pitt et al 1999 Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma J Surg Res 84 88-93 10334895 1:CAS:528:DyaK1MXjtFKhtrk%3D 10.1006/jsre.1999.5615
48. K Ichikawa J Imura H Kawamata J Takeda T Fujimori 2002 Down-regulated p16 expression predicts poor prognosis in patients with extrahepatic biliary tract carcinomas Int J Oncol 20 453-61 11836554 1:STN:280:DC%2BD387gs1Sqsg%3D%3D
49. B Klump CJ Hsieh S Dette K Holzmann R Kiebetalich M Jung et al 2003 Promoter methylation of INK4a/ARF as detected in bile - Significance for the differential diagnosis in biliary disease Clin Cancer Res 9 1773-8 12738733 1:CAS:528:DC%2BD3sXjsFeit7g%3D
50. T Ueki AW Hsing YT Gao BS Wang MC Shen J Cheng et al 2004 Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China Clin Cancer Res 10 1717-25 15014024 1:CAS:528:DC%2BD2cXhvFCltrg%3D 10.1158/1078-0432.CCR-1137-3
51. N Wong L Li K Tsang PB Lai KF To PJ Johnson 2002 Frequent loss of chromosome 3P and hypermethylation of RASSF1A in cholangiocarcinoma J Hepatol 37 633-9 12399230 1:CAS:528:DC%2BD38XotVKktLw%3D 10.1016/ S0168-8278(02)00269-6
52. R Dammann C Li JH Yoon PL Chin S Bates GP Pfeifer 2000 Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 Nat Genet 25 315-19 10888881 1:CAS:528:DC%2BD3cXkvFKks7o%3D 10.1038/77083
53. DG Burbee E Forgacs S Zochbauer-Muller L Shivakumar K Fong B Gao et al 2001 Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression J Natl Cancer Inst 93 691-9 11333291 1:CAS:528:DC%2BD3MXjvVamu7o%3D 10.1093/jnci/93.9.691
54. N Wong L Li K Tsang PB Lai KF To PJ Johnson 2002 Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma J Hepatol 37 633-9 12399230 1:CAS:528:DC%2BD38XotVKktLw%3D 10.1016/ S0168-8278(02)00269-6
55. MG Lee HY Kim DS Byun SJ Lee CH Lee JI Kim e al. 2001 Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma Cancer Res 61 6688-92 11559536 1:CAS:528:DC%2BD3MXntFais70%3D
56. R Dammann G Yang GP Pfeifer 2001 Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers Cancer Res 61 3105-9 11306494 1:CAS:528:DC%2BD3MXivFGqsLY%3D
57. YJ Chen QB Tang SQ Zou 2005 Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma World J Gastroenterol 11 1333-8 15761971 1:CAS:528:DC%2BD2MXjt1yqsLc%3D
58. A Weith GM Brodeur GA Bruns TC Matise D Mischke D Nizetic et al 1996 Report of the second international workshop on human chromosome 1 mapping 1995 Cytogenet Cell Genet 72 114-44 8978760 1:STN:280:ByiC3szjs1c%3D
59. S Ishino N Hashimoto S Fushiki K Date T Mori M Fujimoto et al 1998 Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization Cancer 83 360-6 9669820 1:STN:280:DyaK1czjt1CrsQ%3D%3D 10.1002/ (SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q
60. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 93 9821-6 8790415 1:CAS:528:DyaK28XlsFeht7Y%3D 10.1073/pnas.93.18.9821
61. QL Li K Ito C Sakakura H Fukamachi K Inoue XZ Chi et al 2002 Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 109 113-24 11955451 1:CAS:528:DC%2BD38XjtVOntLs%3D 10.1016/ S0092-8674(02)00690-6
62. M Wada S Yazumi S Takaishi K Hasegawa M Sawada H Tanaka et al. 2004 Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines Oncogene 23 2401-7 14743205 1:CAS:528:DC%2BD2cXisVGksLs%3D 10.1038/sj.onc.1207395
63. LP Deiss E Feinstein H Berissi O Cohen A Kimchi 1995 Identification of a novel serine/threonine kinase and a novel 15-Kd protein as potential mediators of the gamma interferon-induced cell death Genes Dev 9 15-30 7828849 1:CAS:528:DyaK2MXjtFWqtL0%3D
64. O Cohen E Feinstein A Kimichi 1997 DAP kinase is Ca2+/ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity EMBO J 16 998-1008 9118961 1:CAS:528:DyaK2sXitF2nsrc%3D 10.1093/emboj/16.5.998
65. E Feinstein T Druck K Kastury H Berissi SA Goodart J Overhauser et al 1995 Assignment of DAP1 and DAPK genes that positively mediate programmed cell death triggered by IFN-gamma to chromosome regions 5p12.2 and 9p34.1, respectively Genomics 29 305-7 8530096 1:CAS:528:DyaK2MXotF2gs74%3D 10.1006/geno.1995.1255
66. JL Kissil E Feinstein O Cohen et al 1997 DAP kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: Possible implications for role as tumor suppressor gene Oncogene 15 403-7 9242376 1:CAS:528:DyaK2sXlt1Sqtbk%3D 10.1038/sj.onc.1201172
67. M Esteller M Sanchez-Cespedes R Rosell et al 1999 Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res 59 67-70 9892187 1:CAS:528:DyaK1MXmsFOhug%3D%3D
68. M Sanchez-Cespedes M Esteller L Wu et al 2000 Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res 60 892-5 10706101 1:CAS:528:DC%2BD3cXhs1Shsrw%3D
69. RA katzenellenbogen SB Baylin JG Herman 1999 Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies Blood 93 4347-53 10361133 1:CAS:528:DyaK1MXjvVGrtLc%3D
70. DJ Simpson R Clayton WE Farrell 2002 Preferential loss of death-associated protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion Oncogene 21 1217-24 11850841 1:CAS:528:DC%2BD38XitFSjtrc%3D 10.1038/ sj.onc.1205195
71. DH Kim HH Nelson JK Wiencke et al 2001 Promoter methylation of DAP-kinase: Association with advanced stage in non-small cell lung cancer Oncogene 20 1765-70 11313923 1:CAS:528:DC%2BD3MXivFKhsbs%3D 10.1038/sj.onc.1204302
72. Y Tada M Wada K Taguchi et al 2002 The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers Cancer Res 62 4048-53 12124340 1:CAS:528:DC%2BD38XlsV2lsb8%3D
73. X Tang FR Khuri JJ Lee et al 2001 Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer Oncogene 20 1765-70 10.1038/ sj.onc.1204667
74. D Kogel JHM Prehn KH Scheidann 2001 The DAP kinase family of pro-apoptotic proteins: Novel players in the apoptotic game Bioassays 23 352-8 1:CAS:528:DC%2BD3MXptVOjtbw%3D 10.1002/bies.1050
75. C Coulonidre JH Miller 1997 Genetic studies of the lac repressor. IV. Mutagenic specificity in the lacI gene of Escherichia coli J Mol Biol 117 577-606 10.1016/0022-2836(77)90059-6
76. AE Pegg 1990 Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents Cancer Res 50 6119-29 2205376 1:CAS:528:DyaK3cXmtVOisLs%3D
77. R Kolodner 1996 Biochemistry and genetics of eukaryotic mismatch repair Genes Dev 10 1433-42 8666228 1:CAS:528:DyaK28XjvVOhsbs%3D
78. SN Thibodeau AJ French PC Roche et al 1996 Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes Cancer Res 56 4836-40 8895729 1:CAS:528:DyaK28XmsFygsLk%3D
79. N Kohya K Miyazaki S Matsukura H Yakushiji Y Kitajima K Kitahara et al 2002 Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma Ann Surg Oncol 9 371-9 11986189 10.1245/aso.2002.9.4.371
80. WC Su SC Shiesh HS Liu CY Chen NH Chow XZ Lin 2001 Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders Dig Dis Sci 46 1387-92 11478488 1:CAS:528:DC%2BD3MXlvFOhtbg%3D 10.1023/A:1010619316436
81. S Kubicka F Kuhnel P Flemming B Hain N Kezmic KL Rudolph et al. 2001 K-ras mutations in the bile of patients with primary sclerosing cholangitis Gut 48 403-8 11171833 1:CAS:528:DC%2BD3MXitlCjurg%3D 10.1136/ gut.48.3.403
82. A Nakeeb PA Lipsett KD Lillemoe MK Fox-Talbot J Coleman JL Cameron et al 1996 Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma Am J Surg 171 147-52 8554130 1:STN:280:BymC2c3htVc%3D 10.1016/S0002-9610(99)80090-7
83. T Takahashi M Suzuki H Shigematsu N Shivapurkar C Echebiri M Nomura et al 2005 Aberrant methylation of Reprimo in human malignancies Int J Cancer 115 503-10 15700311 1:CAS:528:DC%2BD2MXksFKisbY%3D 10.1002/ ijc.20910